➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Baxter
Medtronic
Mallinckrodt
Johnson and Johnson

Last Updated: April 12, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: epoprostenol sodium

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

epoprostenol sodium

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Teva Pharms Usa EPOPROSTENOL SODIUM epoprostenol sodium INJECTABLE;INJECTION 078396 ANDA Teva Parenteral Medicines, Inc. 0703-1985-01 1 VIAL in 1 CARTON (0703-1985-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Teva Pharms Usa EPOPROSTENOL SODIUM epoprostenol sodium INJECTABLE;INJECTION 078396 ANDA Teva Parenteral Medicines, Inc. 0703-1995-01 1 VIAL in 1 CARTON (0703-1995-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Teva Pharms Usa EPOPROSTENOL SODIUM epoprostenol sodium INJECTABLE;INJECTION 078396 ANDA Teva Parenteral Medicines, Inc. 0703-9258-09 2 VIAL in 1 TRAY (0703-9258-09) > 50 mL in 1 VIAL (0703-9258-01)
Glaxosmithkline Llc FLOLAN epoprostenol sodium INJECTABLE;INJECTION 020444 NDA GlaxoSmithKline LLC 0173-0517-00 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0173-0517-00)
Glaxosmithkline Llc FLOLAN epoprostenol sodium INJECTABLE;INJECTION 020444 NDA GlaxoSmithKline LLC 0173-0519-00 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0173-0519-00)
Glaxosmithkline Llc FLOLAN epoprostenol sodium INJECTABLE;INJECTION 020444 NDA GlaxoSmithKline LLC 0173-0857-02 2 VIAL in 1 TRAY (0173-0857-02) > 50 mL in 1 VIAL
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Express Scripts
Baxter
Harvard Business School
McKesson